Gür-Çetinkaya P, Çağdaş-Ayvaz DN, Öksüz AB, et al. Advantage of the subcutaneous immunoglobulin replacement therapy in primary immunodeficient patients with or without secondary protein loss. Turk J Pediatr. 2018;60(3):270-276. doi:10.24953/turkjped.2018.03.006